Bills › 90th General Assembly
HSB 590
Where it is now
- Done: IntroducedJanuary 18, 2024
- Done: SubcommitteeJanuary 18, 2024
- Stopped: House committeeDied when the General Assembly ended
- Next: Passes the House
- Next: Senate committee
- Next: Passes the Senate
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2024 session adjourned on April 19, 2024, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
AI summary Drug manufacturers and wholesalers would be stopped from blocking or making it harder for certain healthcare providers and pharmacies to buy 340B drugs. These companies also could not force providers to follow extra reporting rules or contract terms that aren't already required by law. This rule applies unless the United States Department of Health and Human Services says otherwise.1
Read the official explanation
This bill relates to manufacturers and wholesalers of 340B drugs. “340B drug”, “manufacturer”, and “wholesaler” are defined in the bill. The bill prohibits a manufacturer or wholesaler from, directly or indirectly, denying, restricting, or interfering with either the acquisition or purchase of a 340B drug by a covered entity, or the delivery of a 340B drug to a H.F. _____ contract pharmacy, unless otherwise prohibited by the United States department of health and human services. The bill prohibits a manufacturer or wholesaler from requiring reporting requirements or imposing contractual restrictions that are not required by law in order for a covered entity or contract pharmacy to purchase and receive 340B drugs.
House subcommittee
Named January 18, 2024. Meeting: Tuesday, January 23 · 1:15 PM · RM 103, Sup. Ct. Chamber (Cancelled).
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Iowa Code it changes
Lobbying
7 for · 6 against · 6 undecided · Who →